Glycomic immunotherapies

Nature appears to have taken full advantage of the vast diversity of glycans expressed in organisms by evolving protein modules to recognize discrete glycans that mediate specific physiological or pathological processes. Excluding glycan-specific antibodies, GBPs broadly into two major groups such as lectins and glycosaminoglycan-binding proteins. Most lectins are members of families with defined “carbohydrate-recognition domains” (CRDs) that apparently evolved from shared ancestral genes, often retaining specific features of primary amino acid sequence or three-dimensional structure. Thus, new family members can be identified by searching protein sequence or structural databases.

    Related Conference of Glycomic immunotherapies

    June 26-28, 2017

    3rd Glycobiology World Congress

    London, UK
    September 18-20, 2017

    9th International Conference on Structural Biology

    Zurich, Switzerland
    September 21-22, 2017

    International Conference on Glycobiology

    Houston, Texas, USA
    September 28-29, 2017

    2nd International Conference on Biochemistry

    Dubai, UAE
    October 12-13, 2017

    Global Proteomics Conference

    Dubai, UAE
    October 30 - November 01, 2017

    3rd International Conference on Transcriptomics

    Bangkok, Thailand
    November 13-15, 2017

    9th International Conference and Expo on Proteomics

    Paris, France
    November 13-14, 2017

    9th International Conference on Bioinformatics

    Paris, France
    December 07-09, 2017

    Biochemistry- 2017 (CME & CPD Accredited)

    Frankfurt, Germany

    Glycomic immunotherapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in